Search results for novo nordisk
Novo Nordisk has entered a global licence agreement with French biotechnology company C2X Pharma and the French national institute for health and med
read more »
Discuss Add this link to... Bury
Discuss Add this link to... Bury
Novo Nordisk A/S announced that TransTech has acquired all rights from Novo Nordisk to a portfolio of drug candidates being developed to treat metabo
read more »
Discuss Add this link to... Bury
Discuss Add this link to... Bury
Posted by
worldpharmanews
171 days ago
(http://www.ehealthnews.eu)
Category: Research & Development |
Discuss Add this link to... Bury
Novo Nordisk will donate a licence to its small molecule compound library to the National Center for Drug Screening (NCDS) affiliated to Shanghai Institute of Materia Medica, Chinese Academy of Scien
read more »
Discuss Add this link to... Bury
Discuss Add this link to... Bury
A team of researchers from Novo Nordisk is nominated for Europe's top innovation prize, Inventor of the Year 2008 Award, that will be presented at a ceremony in Ljubljana, Slovenia, on 6 May by the
read more »
Discuss Add this link to... Bury
Discuss Add this link to... Bury
Novo Nordisk A/S (NYSE:NVO) and Neose Technologies, Inc. (Nasdaq GM: NTEC) announced that Novo Nordisk has completed the initial phase 1 clinical trial with NN7128 (GlycoPEGylated factor VIIa), a lon
read more »
Discuss Add this link to... Bury
Discuss Add this link to... Bury
Novo Nordisk has suspended one of its employees after the employee yesterday was charged by the Danish Public Prosecutor for Serious Economic Crime with unlawful insider trading in the company's sha
read more »
Discuss Add this link to... Bury
Discuss Add this link to... Bury
Yesterday, the Danish Minister for Development Cooperation Ms Ulla Tørnæs handed over a torch to Executive Vice President Lise Kingo, Novo Nordisk, at a ceremony in Copenhagen. With the torch Ms Tørn
read more »
Discuss Add this link to... Bury
Discuss Add this link to... Bury
Novo Nordisk announced the launch of a next generation of FlexPen® at the European Association for the Study of Diabetes (EASD) Annual Meeting. The new insulin injection device builds upon the high s
read more »
Discuss Add this link to... Bury
Discuss Add this link to... Bury
Novo Nordisk today announced that it has signed an agreement to acquire intellectual property rights from Neose Technologies Inc. related to Neose's proprietary GlycoPEGylation technology. The acqui
read more »
Discuss Add this link to... Bury
Discuss Add this link to... Bury
